Posts Tagged ‘Drug’

Reducing Breast Density

Posted on: July 6th, 2018 by admin 2 Comments

It is well established that women with dense breast tissue (seen at right) have an increased risk – of four- to six-fold […]

Pioneers in Immunotherapy

Posted on: June 8th, 2018 by admin 2 Comments

The intramural research programme within the National Institutes of Health (NIH) in Bethesda, Maryland lives by its byline: “Our research […]

Inspiring New Ways

Posted on: June 1st, 2018 by admin 1 Comment

The Africa Health Exhibition took place at Gallagher Convention Centre in Midrand, half way between Johannesburg and Pretoria over the past three […]

Dreaming of a Better Diagnosis

Posted on: April 27th, 2018 by admin

Twelve years ago researchers at IBM established the DREAM (Dialogue for Reverse Engineering Assessment and Methods) Challenges, an open science, crowdsourcing effort […]

Searching for the Silver Bullet

Posted on: March 30th, 2018 by admin 2 Comments

A new family of anti-cancer drugs based on the metal silver has been discovered by researchers working at the University […]

Spotlight on Imaging Costs

Posted on: March 16th, 2018 by admin 2 Comments

Why is health care spending in the United States so much greater than in other high-income countries? That’s the provocative […]

An Old Drug Grabs New Attention

Posted on: February 23rd, 2018 by admin 1 Comment

The drug thalidomide, given to pregnant women in the late 1950s, was responsible for serious birth defects that led to its […]

Approval of “Living Drug” to Treat Cancer

Posted on: September 1st, 2017 by admin 4 Comments

In 2012 six-year-old Emily Whitehead was diagnosed with acute lymphoblastic leukaemia and, since she did not respond to standard treatment, was near […]

A Dangerous Outburst

Posted on: July 7th, 2017 by admin 2 Comments

Iatrogenic derives from the Greek words iatros, meaning physician, and genein which means to produce, and may be defined as any adverse […]

A Tale of Greed

Posted on: April 21st, 2017 by admin 4 Comments

Last month we reported that Swiss pharmaceutical manufacturer Roche, which owns the patent for the breast cancer drug Herceptin, had set the […]